Biggest Bottleneck in AI Buildup Drives DRAM ETF to Record 10 Billion Assets Apples AI Strategy Could Revive Growth as Analyst Sets Bullish New Target Vanda Pharmaceuticals VNDA Stock Analysis 172 Loss Key Levels 20260516 Major MA Activity in 2025 A Year of Strategic Consolidation Why Companies Pay Dividends Key Insights for Investors in 2026